FF:10587-108D2: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{f5samples |id=FF:10587-108D2 |name= |sample_id=10587 |rna_tube_id=108D2 |rna_box=108 |rna_position=D2 |sample_cell_lot= |sample_cell_catalog=RCB0431 |sample_company=RIKEN Bi...") |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
|ancestors_in_anatomy_facet=UBERON:0000468,UBERON:0001255,UBERON:0002100,UBERON:0000483,UBERON:0004645,UBERON:0005910,UBERON:0000479,UBERON:0000344,UBERON:0000064,UBERON:0004119,UBERON:0000466,UBERON:0002075,UBERON:0000062,UBERON:0000475,UBERON:0004120,UBERON:0000077,UBERON:0006554,UBERON:0000061,UBERON:0000465,UBERON:0005911,UBERON:0004923,UBERON:0002553,UBERON:0000477,UBERON:0000467,UBERON:0000060,UBERON:0001062,UBERON:0000480,UBERON:0000119,UBERON:0003103,UBERON:0002323,UBERON:0000489,UBERON:0003350,UBERON:0005177,UBERON:0000486,UBERON:0000464,UBERON:0004458,UBERON:0010317,UBERON:0000365,UBERON:0001556,UBERON:0001008,UBERON:0001256,UBERON:0001259 | |||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000548,CL:0000066,CL:0000255,CL:1001319,CL:1000600 | |||
|ancestors_in_disease_facet=DOID:4,DOID:162,DOID:14566,DOID:0050687,DOID:305 | |||
|ancestors_in_ff_facet=FF:0000102,FF:0000003,FF:0000210,FF:0000101,FF:0000001,FF:0100297,FF:0101120,FF:0102868,FF:0100792,FF:0102869,FF:0101345 | |||
|comment= | |||
|created_by= | |||
|creation_date= | |||
|def= | |||
|f5samples= | |||
|ffid_belonging_in_development=UBERON:0002532,UBERON:0006595,UBERON:0006603,UBERON:0010316 | |||
|ancestors_in_anatomy_facet=UBERON: | |||
| | |||
|fonse_cell_line= | |fonse_cell_line= | ||
|fonse_cell_line_closure= | |fonse_cell_line_closure= | ||
Line 66: | Line 36: | ||
|fonse_treatment= | |fonse_treatment= | ||
|fonse_treatment_closure= | |fonse_treatment_closure= | ||
|has_quality= | |||
|id=FF:10587-108D2 | |||
|is_a=EFO:0002090;;FF:0000210;;FF:0101345 | |||
|is_obsolete= | |||
|name= | |||
|namespace=FANTOM5 | |||
|part_of= | |||
|profile_cagescan= | |||
|profile_hcage=,,,IN_LIBRARIAN | |||
|profile_rnaseq= | |||
|profile_srnaseq= | |||
|rna_box=108 | |||
|rna_catalog_number= | |||
|rna_concentration=0.34798 | |||
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0 | |||
|rna_lot_number= | |||
|rna_od260/230=1.64 | |||
|rna_od260/280=2.06 | |||
|rna_position=D2 | |||
|rna_rin= | |||
|rna_sample_type=total RNA | |||
|rna_tube_id=108D2 | |||
|rna_weight_ug=16.35506 | |||
|sample_age=81 | |||
|sample_cell_catalog=RCB0431 | |||
|sample_cell_line=T24 | |||
|sample_cell_lot= | |||
|sample_cell_type=unclassifiable | |||
|sample_collaboration=Yukio Nakamura (RIKEN BRC) | |||
|sample_company=RIKEN Bioresource centre | |||
|sample_description= | |||
|sample_dev_stage= | |||
|sample_disease=transitional-cell carcinoma | |||
|sample_donor(cell lot)= | |||
|sample_ethnicity=unknown | |||
|sample_experimental_condition= | |||
|sample_id=10587 | |||
|sample_note= | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=bladder | |||
|top_motifs= | |top_motifs= | ||
|xref= | |||
}} | }} |
Latest revision as of 19:25, 9 July 2012
Name: | |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
FANTOM5 (FF) ontology
Direct parent terms
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000548 (animal cell)
0000066 (epithelial cell)
0000255 (eukaryotic cell)
1001319 (bladder cell)
1000600 (lower urinary tract cell)
DOID: Disease
4 (disease)
162 (cancer)
14566 (disease of cellular proliferation)
0050687 (cell type cancer)
305 (carcinoma)
UBERON: Anatomy
0000468 (multi-cellular organism)
0001255 (urinary bladder)
0002100 (trunk)
0000483 (epithelium)
0004645 (urinary bladder urothelium)
0005910 (transitional epithelium)
0000479 (tissue)
0000344 (mucosa)
0000064 (organ part)
0004119 (endoderm-derived structure)
0000466 (immaterial anatomical entity)
0002075 (viscus)
0000062 (organ)
0000475 (organism subdivision)
0004120 (mesoderm-derived structure)
0000077 (mixed endoderm/mesoderm-derived structure)
0006554 (urinary system structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0005911 (endo-epithelium)
0004923 (organ component layer)
0002553 (anatomical cavity)
0000477 (anatomical cluster)
0000467 (anatomical system)
0000060 (anatomical wall)
0001062 (anatomical entity)
0000480 (anatomical group)
0000119 (cell layer)
0003103 (compound organ)
0002323 (body cavity)
0000489 (cavitated compound organ)
0003350 (epithelium of mucosa)
0005177 (trunk region element)
0000486 (multilaminar epithelium)
0000464 (anatomical space)
0004458 (body cavity or lining)
0010317 (germ layer / neural crest derived structure)
0000365 (urothelium)
0001556 (lower urinary tract)
0001008 (renal system)
0001256 (wall of urinary bladder)
0001259 (mucosa of urinary bladder)
FF: FANTOM5
0000102 (sample by type)
0000003 (cell line sample)
0000210 (human sample)
0000101 (sample by species)
0000001 (sample)
0100297 (carcinoma cell line sample)
0101120 (epithelial cell line sample)
0102868 (bladder transitional cell carcinoma cell line sample)
0100792 (urinary bladder cancer cell line sample)
0102869 (transitional cell carcinoma cell line sample)
0101345 (T-24 cell)
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
UBERON:0002532 (epiblast (generic))
UBERON:0006595 (presumptive endoderm)
UBERON:0006603 (presumptive mesoderm)
UBERON:0010316 (germ layer / neural crest)